Literature DB >> 26826261

Effects of Ethanol Lock Therapy on Central Line Infections and Mechanical Problems in Children With Intestinal Failure.

Jasmeet S Mokha1, Zev H Davidovics1, Kate Samela1, Karan Emerick1.   

Abstract

OBJECTIVES: Although use of 70% ethanol lock therapy (ELT) has been shown to decrease the rate of catheter-related bloodstream infections (CRBSIs) in patients with intestinal failure and central venous catheters (CVCs), concerns have been raised about its association with higher rates of mechanical problems and CVC replacements (CVC-Rs). We sought to compare the rates of CRBSI, mechanical problems, and CVC-Rs in a cohort of pediatric patients with intestinal failure, with and without ELT (ELT+ and ELT-, respectively).
METHODS: Data were collected in a retrospective chart review from February 2007 to May 2014. Mann-Whitney and Wilcoxon signed-rank tests were used to compare nonparametric and paired data, respectively.
RESULTS: Twenty-nine children had 9033 catheter days (CDs). The ELT+ group (vs ELT-) had lower rate of infection and significantly fewer CVC-Rs due to infection but significantly more mechanical events and related CVC-Rs with significantly shorter mean CVC survival. In 13 children who had a pre-ELT and post-ELT period, ELT was associated with a decrease in the rate of CVC-Rs due to infection (0.36 vs 4.74/1000 CDs, P = .046) and an increase in the rate of CVC-Rs due to mechanical problems (5.05 vs 0/1000 CDs, P = .018).
CONCLUSIONS: While ELT+ is associated with a lower rate of CRBSIs and related CVC-Rs, it is also associated with higher rates of mechanical problems and related CVC-Rs. In addition to investigating the ideal concentration, duration, and timing of ELT to preserve the integrity of the CVC, alternatives to exclusively ethanol-based lock solutions should be developed.

Entities:  

Keywords:  catheter-related bloodstream infections; ethanol lock therapy; intestinal failure; intestinal rehabilitation

Mesh:

Substances:

Year:  2016        PMID: 26826261     DOI: 10.1177/0148607115625057

Source DB:  PubMed          Journal:  JPEN J Parenter Enteral Nutr        ISSN: 0148-6071            Impact factor:   4.016


  7 in total

Review 1.  Redefining short bowel syndrome in the 21st century.

Authors:  Valeria C Cohran; Joshua D Prozialeck; Conrad R Cole
Journal:  Pediatr Res       Date:  2016-12-20       Impact factor: 3.756

2.  Efficacy of ethanol locks to reduce the incidence of catheter-related bloodstream infections for home parenteral nutrition pediatric patients: comparison of therapeutic treatment with prophylactic treatment.

Authors:  Takafumi Kawano; Tatsuru Kaji; Shun Onishi; Koji Yamada; Waka Yamada; Kazuhiko Nakame; Motoi Mukai; Satoshi Ieiri
Journal:  Pediatr Surg Int       Date:  2016-07-26       Impact factor: 1.827

3.  Systematic Review and Meta-Analysis of the Utilization of Ethanol Locks in Pediatric Patients With Intestinal Failure.

Authors:  Riad Rahhal; Maisam A Abu-El-Haija; Lin Fei; Dawn Ebach; Sarah Orkin; Elizabeth Kiscaden; Conrad R Cole
Journal:  JPEN J Parenter Enteral Nutr       Date:  2017-12-19       Impact factor: 4.016

4.  How Broad Should Gram-Negative Coverage Be for Febrile Parenteral Nutrition Dependent Short Bowel Syndrome Patients?

Authors:  Jeremy S Stultz; James H Fly; Bindiya Bagga; Sandra R Arnold; Anushree Algotar; Kelley R Lee
Journal:  J Pediatr Gastroenterol Nutr       Date:  2022-01-18       Impact factor: 3.288

5.  Focal Adhesion Kinase Inhibitor Inhibits the Oxidative Damage Induced by Central Venous Catheter via Abolishing Focal Adhesion Kinase-Protein Kinase B Pathway Activation.

Authors:  Yanru Wang; Sulan Lin; Ping Jiang; Yunlin Song; Yanjie Zhao; Yujian Zheng
Journal:  Biomed Res Int       Date:  2021-03-01       Impact factor: 3.411

Review 6.  Intestinal failure: a review.

Authors:  Philip Allan; Simon Lal
Journal:  F1000Res       Date:  2018-01-18

Review 7.  Non-Antibiotic Antimicrobial Catheter Lock Solutions in Patients on Home Parenteral Nutrition.

Authors:  Jessica Noelting; Brian Jurewitsch; Johane P Allard
Journal:  Nutrients       Date:  2018-08-25       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.